BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed partial clinical hold on Phase 3 study of BNT316/ONC-392 (gotistobart) in ...

The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and ...

Bladder cancer is a relatively small indication for Trodelvy, representing less than 10% of the drug’s sales, Gilead’s CFO ...

BioNTech (NASDAQ:BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for their drug ...

Dr. Kurdi received his Medical Degree with honors from The Faculty of Medicine of Damascus University. Dr. Kurdi also completed his residency at St. Joseph Mercy Hospital, Oakland, MI, a fellowship in ...

Gilead in 2021 won the FDA accelerated nod for Trodelvy in metastatic urothelial cancer, but continued approval was contingent on the outcome of a confirmatory study. The company in late May said that ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the ...

Panelists discuss how biomarker testing is currently utilized in the management of patients with small cell lung cancer (SCLC), including its timing within the treatment journey, while also exploring ...

However, alongside these accolades, Iowa has been climbing the ranks in two more alarming categories: obesity and cancer.

After a recent study found Native Americans are 73% more likely to die from cancer than the general population, OU Health ...

NC State’s DJ Jackson played with Tylee Craft in high school, but their friendship blossomed as they both experienced medical ...

After lung cancer, breast cancer is the number two fatal disease for American women. But men are also subject to breast cancer. According to the American Cancer Society, in 2024, nearly 370,000 women ...